Identifying early progressors following treatment for Glioblastoma (GBM) is paramount in GBM management. MRI-RT platforms provide opportunity for daily MRI of patients. We identified early changes in tumor volume typically starting week 3 or 4 of treatment. We hypothesize tumor volume kinetics are associated with outcome and allow for adapting treatment. We develop a deep learning solution for automatic volume delineation on daily scans, allowing real time monitoring of tumor changes and reducing time burden of segmentation. We obtained DSC for tumor lesion and resection cavity on training and test datasets (mean±standard deviation) 0.87±0.128 and 0.9±0.122; 0.74±0.233 and 0.8±0.277, respectively.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords